Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
2.
Cell Host Microbe ; 16(1): 43-54, 2014 Jul 09.
Article in English | MEDLINE | ID: mdl-25011107

ABSTRACT

Human cytomegalovirus (HCMV) can establish latent infection in hematopoietic progenitor cells (HPCs) or CD14 (+) monocytes. While circularized viral genomes are observed during latency, how viral genomes persist or which viral factors contribute to genome maintenance and/or replication is unclear. Previously, we identified a HCMV cis-acting viral maintenance element (TR element) and showed that HCMV IE1 exon 4 mRNA is expressed in latently infected HPCs. We now show that a smaller IE1 protein species (IE1x4) is expressed in latently infected HPCs. IE1x4 protein expression is required for viral genome persistence and maintenance and replication of a TR element containing plasmid (pTR). Both IE1x4 and the cellular transcription factor Sp1 interact with the TR, and inhibition of Sp1 binding abrogates pTR amplification. Further, IE1x4 interacts with Topoisomerase IIß (TOPOIIß), whose activity is required for pTR amplification. These results identify a HCMV latency-specific factor that promotes viral chromosome maintenance and replication.


Subject(s)
Cytomegalovirus/physiology , DNA Topoisomerases, Type II/metabolism , DNA-Binding Proteins/metabolism , Gene Expression , Host-Pathogen Interactions , Immediate-Early Proteins/metabolism , Virus Latency , Virus Replication , DNA, Viral/metabolism , Gene Expression Profiling , Humans , Immediate-Early Proteins/genetics , Protein Binding , Sp1 Transcription Factor/metabolism
3.
PLoS Pathog ; 9(5): e1003366, 2013.
Article in English | MEDLINE | ID: mdl-23717203

ABSTRACT

The parameters involved in human cytomegalovirus (HCMV) latent infection in CD14 (+) and CD34 (+) cells remain poorly identified. Using next generation sequencing we deduced the transcriptome of HCMV latently infected CD14 (+) and CD34 (+) cells in experimental as well as natural latency settings. The gene expression profile from natural infection in HCMV seropositive donors closely matched experimental latency models, and included two long non-coding RNAs (lncRNAs), RNA4.9 and RNA2.7 as well as the mRNAs encoding replication factors UL84 and UL44. Chromatin immunoprecipitation assays on experimentally infected CD14 (+) monocytes followed by next generation sequencing (ChIP-Seq) were employed to demonstrate both UL84 and UL44 proteins interacted with the latent viral genome and overlapped at 5 of the 8 loci identified. RNA4.9 interacts with components of the polycomb repression complex (PRC) as well as with the MIE promoter region where the enrichment of the repressive H3K27me3 mark suggests that this lncRNA represses transcription. Formaldehyde Assisted Isolation of Regulatory Elements (FAIRE), which identifies nucleosome-depleted viral DNA, was used to confirm that latent mRNAs were associated with actively transcribed, FAIRE analysis also showed that the terminal repeat (TR) region of the latent viral genome is depleted of nucleosomes suggesting that this region may contain an element mediating viral genome maintenance. ChIP assays show that the viral TR region interacts with factors associated with the pre replication complex and a plasmid subclone containing the HCMV TR element persisted in latently infected CD14 (+) monocytes, strongly suggesting that the TR region mediates viral chromosome maintenance.


Subject(s)
Antigens, CD34 , Cytomegalovirus Infections/metabolism , Cytomegalovirus/metabolism , DNA-Binding Proteins/metabolism , Lipopolysaccharide Receptors , Monocytes/metabolism , Polycomb-Group Proteins/metabolism , Viral Proteins/metabolism , Cells, Cultured , Cytomegalovirus/genetics , Cytomegalovirus Infections/genetics , Cytomegalovirus Infections/pathology , DNA-Binding Proteins/genetics , Female , Gene Expression Regulation, Viral/genetics , Genome, Viral/physiology , Histones/genetics , Histones/metabolism , Humans , Male , Monocytes/pathology , Monocytes/virology , Polycomb-Group Proteins/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , RNA, Viral/biosynthesis , RNA, Viral/genetics , Response Elements/genetics , Terminal Repeat Sequences/genetics , Viral Proteins/genetics
4.
J Virol ; 87(10): 5540-53, 2013 May.
Article in English | MEDLINE | ID: mdl-23468496

ABSTRACT

Kaposi's sarcoma-associated herpesvirus (KSHV) is the cause of Kaposi's sarcoma and body cavity lymphoma. In cell culture, KSHV results in a latent infection, and lytic reactivation is usually induced with the expression of K-Rta or by treatment with phorbol 12-myristate 13-acetate (TPA) and/or n-butyrate. Lytic infection is marked by the activation of the entire viral genomic transcription cascade and the production of infectious virus. KSHV-infected cells express a highly abundant, long, noncoding transcript referred to as polyadenylated nuclear RNA (PAN RNA). PAN RNA interacts with specific demethylases and physically binds to the KSHV genome to mediate activation of viral gene expression. A recombinant BACmid lacking the PAN RNA locus fails to express K-Rta and does not produce virus. We now show that the lack of PAN RNA expression results in the failure of the initiation of the entire KSHV transcription program. In addition to previous findings of an interaction with demethylases, we show that PAN RNA binds to protein components of Polycomb repression complex 2 (PRC2). RNA-Seq analysis using cell lines that express PAN RNA shows that transcription involving the expression of proteins involved in cell cycle, immune response, and inflammation is dysregulated. Expression of PAN RNA in various cell types results in an enhanced growth phenotype, higher cell densities, and increased survival compared to control cells. Also, PAN RNA expression mediates a decrease in the production of inflammatory cytokines. These data support a role for PAN RNA as a major global regulator of viral and cellular gene expression.


Subject(s)
Gene Expression Regulation, Viral , Herpesvirus 8, Human/physiology , Host-Pathogen Interactions , RNA, Nuclear/metabolism , RNA, Untranslated/metabolism , RNA, Viral/metabolism , Transcription, Genetic , Herpesvirus 8, Human/pathogenicity , Humans , RNA, Nuclear/genetics , RNA, Untranslated/genetics , RNA, Viral/genetics
5.
J Cell Sci ; 124(Pt 13): 2287-97, 2011 Jul 01.
Article in English | MEDLINE | ID: mdl-21652631

ABSTRACT

Merosin-deficient congenital muscular dystrophy 1A (MDC1A) is a devastating neuromuscular disease that results in children being confined to a wheelchair, requiring ventilator assistance to breathe and premature death. MDC1A is caused by mutations in the LAMA2 gene, which results in the partial or complete loss of laminin-211 and laminin-221, the major laminin isoforms found in the basal lamina of skeletal muscle. MDC1A patients exhibit reduced α7ß1 integrin; however, it is unclear how the secondary loss of α7ß1 integrin contributes to MDC1A disease progression. To investigate whether restoring α7 integrin expression can alleviate the myopathic phenotype observed in MDC1A, we produced transgenic mice that overexpressed the α7 integrin in the skeletal muscle of the dy(W⁻/⁻) mouse model of MDC1A. Enhanced expression of the α7 integrin restored sarcolemmal localization of the α7ß1 integrin to laminin-α2-deficient myofibers, changed the composition of the muscle extracellular matrix, reduced muscle pathology, maintained muscle strength and function and improved the life expectancy of dy(W⁻/⁻) mice. Taken together, these results indicate that enhanced expression of α7 integrin prevents muscle disease progression through augmentation and/or stabilization of the existing extracellular matrix in laminin-α2-deficient mice, and strategies that increase α7 integrin in muscle might provide an innovative approach for the treatment of MDC1A.


Subject(s)
Antigens, CD/biosynthesis , Integrin alpha Chains/biosynthesis , Laminin/metabolism , Muscular Dystrophy, Animal/metabolism , Animals , Disease Progression , Extracellular Matrix/metabolism , Fluorescent Antibody Technique , Integrin alpha Chains/deficiency , Laminin/deficiency , Laminin/genetics , Mice , Mice, Transgenic , Muscle Strength , Muscle, Skeletal/pathology , Muscular Dystrophies/genetics , Muscular Dystrophies/metabolism , Muscular Dystrophy, Animal/pathology , Muscular Dystrophy, Animal/physiopathology , Polymerase Chain Reaction
6.
Circ Res ; 101(7): 672-81, 2007 Sep 28.
Article in English | MEDLINE | ID: mdl-17704212

ABSTRACT

Vascular smooth muscle cell (VSMC) proliferation and migration are underlying factors in the development and progression of cardiovascular disease. Studies have shown that altered expression of vascular integrins and extracellular matrix proteins may contribute to the vascular remodeling observed after arterial injury and during disease. We have recently shown that loss of the alpha7beta1 integrin results in VSMC hyperplasia. To investigate the cellular mechanisms underlying this phenotype, we have examined changes in cell signaling pathways associated with VSMC proliferation. Several studies have demonstrated the mitogen-activated protein kinase signaling pathway is activated in response to vascular injury and disease. In this study, we show that loss of the alpha7 integrin in VSMCs results in activation of the extracellular signal-regulated kinase and translocation of the activated kinase to the nucleus. Forced expression of the alpha7 integrin or use of the mitogen-activated protein kinase kinase 1 inhibitor U0126 in alpha7 integrin-deficient VSMCs suppressed extracellular signal-regulated kinase activation and restored the differentiated phenotype to alpha7 integrin-null cells in a manner dependent on Ras signaling. Alpha7 integrin-null mice displayed profound vascular remodeling in response to injury with pronounced neointimal formation and reduced vascular compliance. These findings demonstrate that the alpha7beta1 integrin negatively regulates extracellular signal-regulated kinase activation and suggests an important role for this integrin as part of a signaling complex regulating VSMC phenotype switching.


Subject(s)
Blood Vessels/physiopathology , Extracellular Signal-Regulated MAP Kinases/metabolism , Integrin alpha Chains/deficiency , Muscle, Smooth, Vascular/metabolism , Muscle, Smooth, Vascular/pathology , Active Transport, Cell Nucleus/genetics , Animals , Antigens, CD/genetics , Antigens, CD/physiology , Blood Vessels/metabolism , Blood Vessels/pathology , Cells, Cultured , Enzyme Activation/genetics , Extracellular Signal-Regulated MAP Kinases/antagonists & inhibitors , Integrin alpha Chains/genetics , Integrin alpha Chains/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Muscle, Smooth, Vascular/physiopathology , Rats
7.
Am J Physiol Gastrointest Liver Physiol ; 292(5): G1315-22, 2007 May.
Article in English | MEDLINE | ID: mdl-17234889

ABSTRACT

Intestinal inflammation causes hyperplasia of smooth muscle that leads to thickening of the smooth muscle layer, resulting in dysmotility. IL-1beta is a proinflammatory cytokine that plays a central role in intestinal inflammation. In this study, to evaluate the effect of IL-1beta on proliferation of ileal smooth muscle cells in vivo, we utilized an organ culture system. When rat ileal smooth muscle tissue was cultured under serum-free conditions for 3 days, most smooth muscle cells maintained their arrangement and kept their contractile phenotype. When 10% FBS was added, an increased number of smooth muscle cells per unit area was observed. Moreover, immunohistochemical staining for PCNA demonstrated that FBS induced proliferation of smooth muscle cells. IL-1beta inhibited the proliferative effect of FBS. Furthermore, IL-1beta upregulated inducible nitric oxide (NO) synthase and cyclooxygenase-2 mRNA and protein and thus stimulated NO and PGE(2) productions. Moreover, exogenously applied NO and PGE(2) inhibited the increase of bromodeoxyuridine-positive cells stimulated with FBS. Immunostaining revealed that the majority of cyclooxygenase-2 and inducible NO synthase was located in the dense network of macrophages resident in the muscularis, which were immunoreactive to ED2. Based on these findings, IL-1beta acts as an anti-proliferative mediator, which acts indirectly through the production of PGE(2) and NO from resident macrophage within ileal smooth muscle tissue.


Subject(s)
Cyclooxygenase 2/biosynthesis , Interleukin-1beta/pharmacology , Nitric Oxide Synthase Type II/biosynthesis , Animals , Cell Proliferation/drug effects , Culture Media, Serum-Free , Enzyme Induction , Ileum/cytology , Ileum/drug effects , Macrophages/physiology , Male , Muscle, Smooth/cytology , Muscle, Smooth/drug effects , Organ Culture Techniques , Proliferating Cell Nuclear Antigen/biosynthesis , RNA, Messenger/metabolism , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...